
In Kovai, tattoos are trending, and studios are growing, yet no rules are in sight.
With tattooing booming among youngsters in Coimbatore, health authorities have been asked to inspect studios, even though there are still no clear rules in place to regulate them.
In Coimbatore, the number of tattoo studios more than doubled in the past three years, from 40 in 2021 to more than 100 today. "A decade ago, there were barely ten tattoo studios in the city. Now, they're as common as beauty parlours, with at least one on every commercial street," says Vaishnavi, founder of Yara Tattoos in Coimbatore.
She adds that most clients are working professionals between the ages of 22 and 30. "Many get names of their partners, spouses, or parents inked.
Women usually prefer butterflies, flowers, and birds, while men often go for tribal designs. Portrait tattoos, especially of deceased loved ones, are also popular. Among religious motifs, Lord Shiva and Murugan's Vel are the most popular, followed by crosses among Christians," she says.
"A 500ml bottle of ink costs anywhere between ₹2,000 and ₹3,000, depending on the quality," says tattoo artist A Gunasekar. "Smaller studios charge ₹200 to ₹300 per square inch, but to cut costs, some may reuse needles and ink, which is risky.
Professional studios charge at least ₹500 per square inch to ensure quality and hygiene."
Dr V Arul Selvan, Associate Professor of Medical Gastroenterology at Coimbatore Medical College Hospital, warns that unsafe practices, especially reusing needles, can spread serious infections such as Hepatitis B, Hepatitis C, and HIV. "Symptoms of hepatitis often appear only after significant liver damage occurs. Patients may experience fatigue, jaundice, abdominal swelling, and in advanced cases, even liver cancer," he says.
"Many people, when asked about risk factors, recall getting tattoos with reused needles. If you're planning to get a tattoo, make sure the studio uses sterile, single-use needles. And if you're prone to skin allergies, always do a patch test first."
N Logu, Secretary of Coimbatore Consumer Voice, has called for stricter regulations. "Tattoo artists and studios must be licensed. Health department officials should regularly inspect studios for cleanliness and proper sterilisation practices," he says.
District health officer Dr P Balusamy adds that the directorate of public health recently directed them to begin inspections. "We don't have official data on how many studios are operating. Only after inspections will we know the actual numbers," he says. While block medical officers have been assigned to inspect studios in rural areas, those within city limits will be covered by the city health officer.
Email your feedback with your name and address to southpole.toi@timesofindia.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
4 hours ago
- Time of India
Bill Gates says Africa will get much of his $200 billion fortune
Microsoft founder Bill Gates recently said his $200 billion fortune would be spent on improving education and healthcare across Africa over the next 20 years. Speaking in Ethiopian capital Addis Ababa this week, the tech billionaire, according to a BBC report, said, 'I recently made a commitment that my wealth will be given away over the next 20 years. Most of that funding will help you tackle challenges here in Africa.' Gates added, 'By unleashing human potential through health and education, every country in Africa should be on a path to prosperity". Alongside this, he also urged Africa's young innovators to think about how to build artificial intelligence (AI) to improve healthcare on the continent. The Bill & Melinda Gates Foundation will stop operating by the time Gates gives away his wealth in 2045. The Microsoft cofounder said the foundation, which has a long history of operating in Africa, would focus on improving primary healthcare. "What we've learned is that helping the mother be healthy and have great nutrition before she gets pregnant, [and] while she is pregnant, delivers the strongest results," he said. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories "Ensuring the child receives good nutrition in their first four years as well makes all the difference," he added. His commitment comes at a time when the US government has cut aid to Africa, including programmes to treat patients with HIV/Aids, as part of US president Donald Trump's "America First" policy. This move has raised concerns about the future of healthcare in Africa.


Mint
4 hours ago
- Mint
A new shot prevents HIV—and breathes new life into a stagnant biotech
Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to prevent HIV—a milestone in the decadeslong fight against a once-devastating disease. For Gilead Sciences, the dominant player in HIV treatment, the breakthrough is doing what years of splashy but underwhelming acquisitions failed to achieve: It has Wall Street paying attention again. Since reporting last June that just two annual shots of lenacapavir prevented all HIV infections in a study of women and girls, shares have surged 73%. Gilead still isn't very expensive: It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, and hardly a stretch for a company on the cusp of a new product cycle. Investors might fear they have seen this movie before. A decade ago, Gilead stock soared on excitement over its hepatitis C cure, only to stall once most patients had been treated and the market dried up. The company then fell into value-trap territory, weighed down by sluggish growth and a string of underwhelming cancer deals. This time could be different—but only if Gilead can execute. Over 400,000 people in the U.S. are currently on pre-exposure prophylaxis, or PrEP—a medication that protects against HIV infection. To hit the $4 billion in annual sales that some analysts are forecasting by the end of the decade, the company will need to not only convert a big chunk of existing patients but also expand the overall market both at home and abroad. Gilead expects the number of users in the U.S. to grow to over one million in the next decade. The early signs are promising. For starters, the market is growing fast. Sales of Gilead's daily pill Descovy rose 38% last quarter from a year ago, while GSK's Apretude—a long-acting injection given every two months—jumped 63%. Secondly, many current and potential users say they would prefer a longer-acting injection. A Jefferies survey of more than 500 PrEP users found that 95% would switch to a twice-yearly injection. In an interview, Gilead's Chief Commercial Officer Johanna Mercier said the key advantage of the company's upcoming HIV prevention shot isn't just efficacy but adherence. 'We know it's challenging to take a daily pill for prevention, and we see an incredible opportunity here," she said, citing data showing that many patients struggle to stay consistent with oral PrEP. Still, hurdles remain. Stigma continues to hinder PrEP uptake, particularly outside the core demographic of white men who have sex with men. Black Americans account for 39% of new HIV diagnoses but just 14% of PrEP users. Expanding access to underserved populations will require continued insurance coverage. While most current users are covered by commercial insurance, Medicaid will be key to reaching lower-income groups—making recent GOP proposals to cut the program a potential threat to Gilead's growth strategy. Another risk, according to RBC Capital Markets analyst Brian Abrahams, is cannibalization. Gilead's daily pill Descovy currently accounts for 40% to 45% of the PrEP market, so some of the lenacapavir growth could come at the expense of its existing business. But Mercier is confident the new product will expand the market both in the U.S. and globally. Gilead is working with governments in countries such as the U.K., where PrEP awareness is low, and planning broader rollout in low-income countries through partnerships with global health organizations. 'We're thinking globally about the public health impact we can have," she said. Gilead's growth outlook means it is, for now, steering clear of the patent cliff that is about to hit much of the industry as multibillion-dollar blockbuster drugs face generic competition. Gilead's HIV blockbuster, Biktarvy—which is prescribed after infection—retains exclusivity until 2033, with several potential successors already in the pipeline. Beyond HIV, Gilead is beginning to show signs of turning the corner in cancer, a space where past acquisitions have frustrated investors. There is growing excitement around Trodelvy—an antibody-drug conjugate acquired via its $21 billion Immunomedics deal—after data showed it delayed progression in an aggressive form of breast cancer when combined with Merck's Keytruda. Meanwhile, Gilead's cell therapy program is gaining traction, with the company aiming to challenge Johnson & Johnson in the multibillion-dollar multiple myeloma market, explains Traver Davis, a healthcare strategist at Citi. 'They have been hammered for their acquisitions and execution on the oncology side of the business in the last few years," said Davis. 'The narrative on that is definitely turning." Gilead spent years trying to move beyond HIV. In the end, it might be HIV prevention that finally delivers the breakthrough investors have been waiting for. Write to David Wainer at


Time of India
5 hours ago
- Time of India
Bill Gates to leave just 1% of $200 Billion wealth to his kids— The rest goes to Africa: Meet the Gates children
Microsoft co-founder has announced a bold pledge: to donate most of his $200 billion fortune over the next 20 years—focusing largely on healthcare and education in Africa. Speaking at the African Union headquarters in Addis Ababa, Ethiopia, Gates emphasized the importance of unlocking human potential as the key to driving prosperity across the continent, as per reports. Tired of too many ads? go ad free now 'The majority of that funding will be spent on helping you address challenges here in Africa,' Gates told an audience of over 12,000 officials, youth leaders, and diplomats. Gates stressed that good health and quality education are essential for development. His foundation will focus on primary healthcare, especially maternal and child health. 'Healthy mothers and proper nutrition— especially in a child's first four years—are vital for long-term success,' he said. He also encouraged African innovators to integrate artificial intelligence into their healthcare systems, much like Rwanda, which uses AI-enabled ultrasounds to detect high-risk pregnancies. 'Africa skipped traditional banking. Now you can leap ahead in healthcare by embracing AI,' Gates noted. Gates' announcement comes at a critical time when foreign aid to Africa has been reduced, particularly under the U.S.'s former "America First" policy. The cuts have impacted vital programs, including HIV/AIDS treatments. A legacy beyond wealth Gates recently declared that he plans to give away 99% of his wealth, aiming to close the Bill & Melinda Gates Foundation in about two decades. 'When I die, I don't want people to say 'he died rich,'' Gates wrote on his blog. Despite giving away nearly all of his fortune, Bloomberg predicts Gates will still remain a billionaire due to investments and market growth. Tired of too many ads? go ad free now Over the years, Bill Gates has been quite vocal about his children inheriting only a miniscule amount of his wealth. Talking about this, he once told told Raj Shamani in an interview, "Well, I think everybody gets to decide on that. In my case, my kids got a great upbringing, education, but less than 1% of the total wealth because I decided it wouldn't be a favour to them. It's not a dynasty. I'm not asking them to run Microsoft. I want to give them a chance to have their own earnings and success, be significant and not overshadowed by the incredible luck and good fortune I had." He added, "Different families see that differently. I think the people who've made fortunes from technology are less dynastic and so they'll even take their capital and give a lot of that away. You can have the view of giving away your capital or just giving away your earnings. And, of course, I love all philanthropy, but the tech sector is probably the most aggressive about giving most of it away." Meet the Gates children During their 27 years of marriage, Bill Gates and Melinda French had three children together-- Jennifer Gates Nassar, Rory Gates, and Phoebe Gates. Jennifer Katharine Gates, born on April 26, 1996, is the eldest daughter of Bill and Melinda Gates. Unlike her tech-icon parents, Jennifer has built a distinct identity—as both a doctor and a professional equestrian. She holds degrees from Stanford, Columbia, and graduated from the Icahn School of Medicine in 2024. She has now begun her pediatric residency at Mt. Sinai. In 2021, she married fellow equestrian Nayel Nassar, just months after her parents' divorce. The couple has two daughters—Leila, born in March 2023, and Mia, born in October 2024. Jennifer continues to balance motherhood, medicine, and equestrian sports. Born on May 23, 1999, Rory John Gates is the only son of Bill and Melinda Gates. Named in honor of Melinda's late friend John Neilson, Rory has quietly built an impressive academic profile. He graduated from the University of Chicago in 2022, earning a double major and a master's degree in just four years. Currently, he's pursuing a PhD at the Institute of World Politics while working as an analyst for the Afghanistan War Commission. Known for his privacy, Rory was described by Melinda as 'compassionate, curious, intelligent, and feminist,' deeply engaged in conversations about gender equality and world issues. And Phoebe Adele Gates, the youngest child of Bill and Melinda Gates, was born on September 14, 2002. Unlike her tech-savvy family, Phoebe has shown a strong interest in fashion. In 2022, she interned with British Vogue, calling it 'the internship of a lifetime.' She also shares her father's love for reading and is active on social media, especially TikTok, where she promotes women's health and sustainable fashion. A 2024 Stanford graduate, Phoebe co-launched The Burnouts podcast in 2025 and co-founded Phia, a sustainable fashion platform set to launch soon. She's currently dating Arthur Donald, Paul McCartney's grandson. What are your views on Bill Gates decision of giving away only 1% of his wealth to his children and the rest to charity? Tell us about it in the comments section below.